Skip to main content

Kat Jercich

Kat Jercich

Kat Jercich is the Senior Editor at Healthcare IT News. Her writing has appeared in the New York Times, the Washington Post, The Advocate, and others. Previously, she was Vice President and Managing Editor at Rewire.News.

By Kat Jercich | 09:17 am | July 15, 2020
VitalSight sends patient blood pressure data directly to Mount Sinai's Epic electronic health record, with an option to alert physicians' offices if a concern is detected.
By Kat Jercich | 02:01 pm | July 14, 2020
Death rates from cancer are higher in rural America – in part because of reduced access to high-quality care.
By Kat Jercich | 12:47 pm | July 13, 2020
Plaintiffs allege that the telehealth giant contracted with a third-party telemarketer that violated the Telephone Consumer Protection Act.
By Kat Jercich | 09:43 am | July 13, 2020
A recent survey found that three-quarters of patients said they were very or completely satisfied with the virtual care they'd received, but many left the visit without understanding the next steps.
By Kat Jercich | 03:14 pm | July 10, 2020
A blog post published in Health Affairs outlines a framework for tracking the effectiveness of stakeholder behavior in response to ONC data-sharing rules.   
Analytics
By Kat Jercich | 01:40 pm | July 09, 2020
A new JAMIA study suggests it's possible to protect sensitive patient data while developing models to ultimately optimize care.
By Kat Jercich | 09:15 am | July 09, 2020
Providers who e-prescribe birth control through apps and online pharmacies doubt the decision will significantly affect their practices, but they say the mandate is harmful for those who need contraception.
By Kat Jercich | 05:37 pm | July 08, 2020
The new preview feature can associate words or phrases in unstructured text with semantic entities, such as symptom, diagnosis and medication dosage.
By Kat Jercich | 09:22 am | July 08, 2020
Patients have generally gone to their doctor's offices to obtain remote monitoring devices – but the pandemic is proving they don't have to.
By Kat Jercich | 12:41 pm | July 07, 2020
The U.S. Department of Health and Human Services also announced it would give $450 million to the biotech company Regeneron to manufacture and supply the company's antibody treatment.  

Newsletter Signup